Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,927	8,212	9,182	9,399	12,460	22,439
Market Cap Growth	-31.30%	-10.57%	-2.31%	-24.57%	-44.47%	29.37%
Enterprise Value	6,771	8,189	8,948	9,046	11,989	21,328
Last Close Price	257.05	310.70	325.60	320.65	404.66	722.91
PE Ratio	9.12	10.81	-	-	-	5.28
PS Ratio	2.68	3.18	3.58	3.52	4.45	7.68
PB Ratio	0.93	1.10	1.40	1.08	1.30	1.64
P/TBV Ratio	1.03	1.23	1.57	1.17	1.40	1.72
P/FCF Ratio	18.49	21.92	31.71	43.08	152.70	41.88
P/OCF Ratio	13.02	15.43	20.17	25.07	64.10	33.52
EV/Sales Ratio	2.62	3.17	3.49	3.39	4.28	7.30
EV/EBITDA Ratio	15.69	18.98	20.23	17.68	19.34	30.37
EV/EBIT Ratio	25.45	30.77	30.77	24.74	24.84	37.77
EV/FCF Ratio	18.08	21.86	30.90	41.46	146.93	39.81
Debt / Equity Ratio	0.19	0.19	0.21	0.16	0.14	0.02
Debt / EBITDA Ratio	2.45	2.45	2.36	2.20	2.05	0.30
Debt / FCF Ratio	3.70	3.70	4.75	6.44	17.01	0.42
Net Debt / Equity Ratio	-0.02	-0.02	-0.04	-0.02	-0.04	-0.05
Net Debt / EBITDA Ratio	-0.36	-0.36	-0.65	-0.39	-0.65	-0.92
Net Debt / FCF Ratio	-0.42	-0.42	-1.00	-0.92	-4.93	-1.21
Asset Turnover	0.26	0.26	0.24	0.21	0.18	0.19
Inventory Turnover	1.65	1.65	1.52	1.65	1.91	2.11
Quick Ratio	3.89	3.89	4.55	4.03	4.04	1.90
Current Ratio	5.62	5.62	6.48	5.83	5.55	2.92
Return on Equity (ROE)	10.84%	10.84%	-24.09%	-6.94%	-31.14%	36.11%
Return on Assets (ROA)	1.67%	1.67%	1.68%	1.77%	1.93%	2.29%
Return on Invested Capital (ROIC)	2.90%	2.99%	3.92%	4.12%	4.34%	3.98%
Return on Capital Employed (ROCE)	2.60%	2.60%	3.30%	3.10%	3.70%	3.30%
Earnings Yield	10.97%	9.25%	-20.08%	-6.78%	-29.11%	18.96%
FCF Yield	5.41%	4.56%	3.15%	2.32%	0.66%	2.39%
Buyback Yield / Dilution	3.31%	3.31%	3.41%	1.93%	1.40%	-0.16%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q